Cargando…
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward
BACKGROUND: The COVID-19 pandemic shows that the impact of effective vaccines can extend well beyond vaccinated individuals and healthcare systems. Yet, these broader value elements are not typically considered in Health Technology Assessment (HTA) which may underestimate vaccines’ broader value. OB...
Autores principales: | Bell, Eleanor, Neri, Margherita, Steuten, Lotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458004/ https://www.ncbi.nlm.nih.gov/pubmed/34553333 http://dx.doi.org/10.1007/s40258-021-00683-z |
Ejemplares similares
-
Realising the broader value of vaccines in the UK
por: Brassel, Simon, et al.
Publicado: (2021) -
PIN62 Recognising the broader value of vaccines in HTA: ready for prime time?
por: Brassel, S., et al.
Publicado: (2021) -
Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?
por: Neri, Margherita, et al.
Publicado: (2023) -
Progress Toward a Gonococcal Vaccine: The Way Forward
por: Russell, Michael W., et al.
Publicado: (2019) -
Brave enough
por: Neville, Thanh H.
Publicado: (2021)